Although other COL7A1 gene replacement approaches have targeted either keratinocytes11 or fibroblasts13, the ability of B-VEC to induce robust C7 expression in both cell types may offer a distinct advantage and may have contributed to the AF formation and wound healing seen in this study. The gene discussed is COL7A1; the disease is atrial fibrillation.